Intravenous infusion of cipaglucosidase alfa-atga, including provider/supplier acquisition and clinical supervision of oral administration of miglustat in preparation of receipt of cipaglucosidase alfa-atga
Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 1 units per day (practitioner), rationale: Code Descriptor / CPT Instruction